Boston Scientific to buy Penumbra in deal valued at $14.5 billion
15/01/2026 12:04
Jan 15 (Reuters) - Boston Scientific BSX.N said on Thursday it will buy Penumbra PEN.N in a deal valued at about $14.5 billion. (Reporting by Mariam Sunny in Bengaluru) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on Boston Scientific
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
U.S. RESEARCH ROUNDUP-Autodesk, Dell Technologies, Hyatt Hotels
Live Markets: Eight trillion reasons UBS wants you to bet on longevity
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
U.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce